Hot Investor Mandate: Therapeutics Accelerator Actively In-Licenses Assets from Pre-Clinical to Early Clinical Stages of Development, Considering Opportunities Across All Modalities

12 May

A therapeutic accelerator looks to in-license therapeutics assets from inventors/founders, and fund the assets’ development through clinical proof-of-concept. The firm is looking for assets throughout the United States and is actively seeking new opportunities. The firm has signed a partnership with a major VC firm, who will advise on current and future investments.

The firm is currently looking for therapeutic assets in pre-clinical through early clinical stages of development. The firm is open in terms of indication and will consider both small molecules and biologics, and will also consider drug repurposing opportunities. The firm looks to in-license these assets and accelerate their development through to clinical proof-of-concept, at which point the firm looks to partner the asset with pharmaceutical firms or other investors who will complete the commercialization of the asset. The firm has signed strategic partnerships with major pharma, regarding products in cardiovascular, metabolic, neuroscience, and immunology indications.

The firm focuses on the strength of the technology when evaluating in-licensing opportunities. The company leverages a capable and connected team and advisors for the development, funding, active management, and partnering of its portfolio of therapeutic products.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: